Mariner
RXST icon

Mariner’s RxSight RXST Stock Holding History

Mariner’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
84,866
+37,139
+78% +$224K ﹤0.01% 2603
2026
Q1 		$294K Buy
47,727
+20,566
+76% +$171K ﹤0.01% 2899
2025
Q4 		$284K Sell
27,161
-3,883
-13% -$39K ﹤0.01% 2895
2025
Q3 		$279K Buy
31,044
+19,180
+162% +$168K ﹤0.01% 2876
2025
Q2 		$154K Buy
+11,864
New +$178K ﹤0.01% 3134
2025
Q1 		– Sell
-12,080
Closed -$415K – 3558
2024
Q4 		$415K Sell
12,080
-274
-2% -$12.4K ﹤0.01% 2338
2024
Q3 		$611K Sell
12,354
-2,194
-15% -$112K ﹤0.01% 1972
2024
Q2 		$875K Buy
14,548
+1,865
+15% +$107K ﹤0.01% 1604
2024
Q1 		$654K Buy
12,683
+1,315
+12% +$64.5K ﹤0.01% 1831
2023
Q4 		$458K Sell
11,368
-822
-7% -$24.1K ﹤0.01% 1995
2023
Q3 		$340K Buy
12,190
+1,232
+11% +$36.7K ﹤0.01% 2047
2023
Q2 		$317K Buy
10,958
+857
+8% +$19.1K ﹤0.01% 2077
2023
Q1 		$168K Buy
+10,101
New +$143K ﹤0.01% 2459

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mariner's RXST Position: Q2 2026 in Review

Mariner increased its RxSight (RXST) stake by 78% in Q2 2026, buying an estimated $224K and bringing the position to 84,866 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Mariner first reported a position in RXST in Q1 2023 and has held it in 13 quarters since. The position peaked at $875K in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Mariner held 84,866 shares of RxSight worth $409K as of Q2 2026.
  • Mariner bought 37,139 RxSight shares in Q2 2026, an estimated $224K.
  • RxSight made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2603 holding.
  • Mariner first reported a position in RxSight in Q1 2023 and has held it in 13 quarters since.
  • Mariner's RxSight position peaked at $875K in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.